P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID‐19: RESULTS OF A MULTICENTER PHASE II TRIAL.

Autor:	Thomopoulos, T., Bouchla, A., Antoniadou, A., Terpos, E., Politou, M., Stamoulis, K., Koromboki, E., Papageorgiou, S., Kotanidou, A., Kalomenidis, I., Jahaj, E., Grigoropoulou, S., Pagoni, M., Grouzi, E., Poulakou, G., Trontzas, I., Labropoulou, S., Mentis, A., Bamias, A., Tsiodras, S.
Zdroj:	HemaSphere; 2022 Supplement 3, Vol. 6, p1510-1511, 2p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text